Accessibility / Report Error
(Updated: 2023/10/16)

About the journal


Basic information


Jornal Brasileiro de Psiquiatria The Jornal Brasileiro de Psiquiatria is the official journal of the Institute of Psychiatry of the Federal University of Rio de Janeiro (IPUB/UFRJ), published quarterly for more than 70 years.

Jornal Brasileiro de Psiquiatria  is a national and international, open access, online publishing forum for the publication of research on the theory and practice of Psychiatry and Mental Health. 

Its abbreviated title is J. bras. psiquiatr, which should be used in bibliographies, footnotes and bibliographical references and strips.




  • Scientific Eletronic Library Online - SciELO
  • American Psychological Association - PsychoINFO
  • British Libray Document Supply Center - BLDSC
  • Excerpta Medica - Embase
  • Scopus
  • Index Medicus Latino-Americano - LILACS
  • Institute de L' Information Scientifique et Techinique - INIST
  • Libray of the Royal Netherlands Academy of Arts and Sciences - KNAW
  • Free Medical Journals - FMJ
  • DOAJ


Intellectual property


All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.




Editorial Board






Associate Editors

  • André Barciela Veras – Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria – Rio de Janeiro, Brasil
  • Andrea Camaz Deslandes - Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria – Rio de Janeiro, Brasil
  • Carlos Eduardo Ferreira de Moraes – Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria – Rio de Janeiro, Brasil
  • Carlos Miguel Martins Campos – Escola Superior de Saúde (ESS), Instituto Politécnico do Porto (IPP) – Porto, Portugal.
  • Felipe Barreto Schuch - Universidade Federal de Santa Maria, Centro de Educação Física e Desporto – Rio Grande do Sul, Brasil
  • Felipe Kenji Sudo – Instituto D’or de Pesquisa e Ensino -  Rio de Janeiro, Brasil
  • Gilberto Sousa Alves – Universidade Federal do Maranhão – Departamento de Medicina – Maranhão, Brasil
  • Laiana Azevedo Quagliato – Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria – Rio de Janeiro, Brasil
  • Liliane Maria Pereira Vilete - Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria – Rio de Janeiro, Brasil
  • Maria Tavares Cavalcanti – Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria, Brasil
  • Mariana Pires da Luz - Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria – Rio de Janeiro, Brasil
  • Morená Mourão Zugliani – Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria – Rio de Janeiro, Brasil
  • Natalia Bezerra Mota – Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria – Rio de Janeiro, Brasil
  • Renato Sobral Monteiro Jr. – Universidade Estadual de Montes Claros -  Minas Gerais, Brasil


Junior Editors

  • Cheyenne Monteiro Wolf von Arcosy – Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria – Rio de Janeiro, Brasil
  • Felipe de Oliveira Silva – Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria – Rio de Janeiro, Brasil
  • Isabel Barbeito de Vasconcellos Lantimant – Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria – Rio de Janeiro, Brasil
  • Raquel Menezes Gonçalves – Universidade Salgado de Oliveira – Rio de Janeiro, Brasil
  • Walter dos Santos Gonçalves – Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria – Rio de Janeiro, Brasil


Editorial Board

  • Albina R. Torres – Universidade Estadual Paulista - Faculdade de Medicina de Botucatu - Departamento de Neurologia Psicologia e Psiquiatria, Brasil
  • Andre Barciela Veras – Universidade Católica Dom Bosco, Pró-Reitoria Acadêmica, Brasil 
  • Antonio Lúcio Teixeira – Universidade Federal de Minas Gerais, Faculdade de Medicina, Brasil
  • Charles Marmar – University of California, USA
  • Christian Kieling – Universidade Federal do Rio Grande do Sul, Faculdade de Medicina, Departamento de Psiquiatria e Medicina Legal, Brasil
  • Christos Pantelis – University of Melbourne, Australia
  • Dan J. Stein – University of Cape Town, South Africa
  • Daniel Correa Mograbi – Pontifícia Universidade Católica do Rio de Janeiro, Brasil
  • Elie Cheniaux Junior – Universidade do Estado do Rio de Janeiro, Faculdade de Ciências Médicas, Brasil
  • Eric A. Storch – University of South Florida, USA
  • Ezra Susser – Columbia University, USA
  • Gilberto Alves – Universidade Federal do Maranhão, Departamento de Medicina, Brasil
  • Graham Thornicroft – King’s College, UK
  • Gregor Hasler – University of Bern, Switzerland
  • Hélio Elkis – Universidade de São Paulo, Faculdade de Medicina, Instituto de Psiquiatria, Brasil
  • Irismar Reis de Oliveira, Universidade Federal da Bahia, Faculdade de Medicina, Bahia, Brasil
  • Jerson Laks – Universidade Estadual do Rio de Janeiro, Faculdade de Ciências Médicas, Brasil
  • José Carlos Appolinário, Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria, Rio de Janeiro, Brasil
  • Júlio Licinio – State University of New York, Upstate Medical University, USA
  • Lara Carneiro - Instituto Universitário da Maia - ISMAI - Maia, Portugal
  • Lucy Albertella – Monash University, Austrália
  • Marcelo Papelbaum – Sheba Medical Center, Israel
  • Marcelo Santos Cruz – Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria, Brasil
  • Maria Lage Barca – Oslo University – Oslo, Noruega
  • Maria Conceição Rosário – Universidade Federal de São Paulo, Escola Paulista de Medicina, Brasil
  • Maria Lage Barca – Oslo University, Noruega
  • Mario Francisco Juruena – King's College London & South London and Maudsley NHS Foundation Trust, UK.
  • Mario Maj – University of Naples, Italy
  • Martin B. Keller – Brown University, USA
  • Michael J. Devlin – University of Columbia, USA  
  • Michael Liebowitz – Columbia University, USA  
  • Murray B. Stein – University of California, USA
  • Myrna Weissman – Columbia University,  USA   
  • Pedro Morgado, Universidade do Minho - Minho, Portugal
  • Ronald Kessler – Harvard University, USA
  • Susan L. McElroy – University of Cincinnati, USA  
  • Ygor A. Ferrão – Universidade de Ciência da Saúde de Porto Alegre,  Brasil


Editorial Support Services

  • Andrea Borges – Universidade Federal do Rio de Janeiro, Instituto de Psiquiatria, Brasil



Instructions to authors


Scope and Editorial Policy


The Journal of Psychiatry of Brazil (JBP) is a peer-reviewed, open-access journal and the official publication of the Institute of Psychiatry of the Federal University of Rio de Janeiro (IPUB/UFRJ), published in a continuous flow for more than 70 years.

The mission of JBP is to contribute to the advancement of clinical and scientific knowledge in psychiatry and mental health through open science, which consists of transparent and accessible knowledge that is shared and developed through collaborative networks. JBP aims to disseminate high-quality research with clinical and scientific impact in Psychiatry and Mental Health.

JBP accepts manuscripts in English and Portuguese, and its published content is licensed under the Creative Commons (CC-BY) Attribution 4.0 International License. The journal publishes the following categories of articles: original articles, brief reports, reviews, editorials, case reports and special articles.

JBP supports and strictly follows the recommendations of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals from the International Committee of Medical Journal Editors (ICMJE), the Committee on Publication Ethics (COPE), the Council of Science Editors (CSE), and the World Association of Medical Editors (WAME).

Acceptance will be based on originality, significance, and scientific contribution.

Articles with purely promotional or commercial objectives will not be accepted. Manuscripts should be submitted in English or Portuguese, employing clear, precise, and concise language, avoiding colloquial language informality. Only manuscripts whose data are not being evaluated by other journals and/or have not been previously published will be considered for evaluation.

Authors are strongly encouraged to use appropriate reporting guidelines when preparing and submitting manuscripts to maximize transparency and reproducibility.

JBP does not charge an Article Processing Charge (APC) for texts submitted for evaluation, review, publication, distribution or download. Publication is completely free and open access.



Research on Human and Experimental Subjects


All studies involving human subjects or human tissue must follow the Declaration of Helsinki ( and must have been approved by the local institutional review board. Thus, in the "Methods" section, authors must identify the approval and ethics committee of the institution that reviewed the study. In addition, authors must describe the methods employed to evaluate the volunteers' capacity to understand and provide informed consent to participate in the study, as well as describe the strategies used in the study to ensure participant protection.

In experimental studies involving animals, the norms established in the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Academy of Sciences, Washington, D.C., USA), 1996, and the Ethical Principles in Animal Experimentation (Brazilian College of Animal Experimentation - COBEA, available at:, 1991, must be followed. This information must be included in the method according to the ARRIVE recommendation -



Ethical Considerations and Research Integrity


The JBP considers ethical integrity to be the cornerstone of scientific research and human care, and therefore supports the recommendations for conducting and publishing research from the Committee on Publication Ethics (COPE), the Council of Science Editors (CSE), and the World Association of Medical Editors (WAME).

Any cases of misconduct will be dealt with according to the appropriate sanctions established by the Editorial Board.

Scientific misconduct and unethical acts include, but are not limited to: plagiarism, duplication and redundant publication, data fabrication, and corrections and retractions.

Research misconduct does not include honest errors or differences of opinion.

Concepts, ideas, or opinions expressed in manuscripts, as well as the accuracy and origin of the citations contained therein, are solely the responsibility of the author(s).

The JBP uses the Similarity Check software, which allows for the detection of similarities in submitted materials.

  • Use of Chatbots, ChatGPT in manuscripts submitted to JBP: to ensure the integrity and reliability of the results and conclusions presented in scientific manuscripts that use Chatbots or ChatGPT and to maintain public confidence in the findings and advances presented, JBP supports WAME recommendations ( on the ethical considerations related to the use of these technologies in scientific manuscripts, which are:
  • Transparency: Authors should be transparent about the use of Chatbots or ChatGPT in the manuscript writing process, including detailed information (name, version, template, and source) about how the technology was used and what role Chatbots or ChatGPT played in the development of the text.
  • Responsibility: Authors must take responsibility for the work done by the Chatbots or ChatGPT in their manuscripts, including the accuracy of what is presented and the absence of plagiarism. Human authors must also be able to affirm that there is no plagiarism in their article, including in the text produced by the Chatbots or ChatGPT.
  • Attribution: Authors must ensure proper attribution of all sources, including material produced by Chatbots or ChatGPT. Authors should also seek out and cite sources that support Chatbots' or ChatGPT's statements.
  •  Limitations: Authors should discuss the limitations and potential biases of using Chatbots or ChatGPT in scientific text production, such as lack of capacity.

Authors should disclose the use of generative AI and AI-assisted technologies in the writing process by adding a statement at the end of the main manuscript file, before the References section. The statement should be placed in a new section titled "Statement of generative AI and AI-assisted technologies in the writing process".

Statement: During the preparation of this paper, the author(s) used [NAME OF TOOL/SERVICE] for the purpose of [REASON]. After using this tool/service, the author(s) have reviewed and edited the content as necessary and take full responsibility for the content of the publication.

This statement does not apply to the use of basic tools for grammar checking, spell checking, references, and so on. If there is nothing to disclose, it is not necessary to add a statement.

Originality and Copyright Statement: Authors retain copyright of the article and agree to grant JBP a license to publish, with the condition that authorship is properly credited and that the original article is properly cited. By submitting the manuscript, authors declare that the work is original and contains no fabrication, fraud, or plagiarism; does not violate any third-party copyright or proprietary rights; is not under consideration for publication in another journal; and has not been published previously. In addition, authors must ensure that each meets the authorship requirements as recommended by the ICMJE (see Manuscript Preparation section) and understand that if the paper or part of it is flawed or fraudulent, each author shares responsibility.



Conflict of Interest Statement


Authors must describe any conflicts of interest that may exist in relation to the research or publication of the article. Failure to declare any existing conflicts of interest constitutes a form of misconduct in research. Conflicts of interest can be financial or non-financial in nature. All authors must fill out the ICMJE declaration form for disclosure of potential conflicts of interest. This document includes a section for declaring conflicts of interest based on the recommendations of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals - The completed form should be submitted along with the manuscript.



Use of Inclusive Language


Inclusive language is an increasingly discussed topic in today's society. It is a form of communication that seeks to include and represent all people, regardless of their gender identity, race, ethnicity, sexual orientation, among other aspects.

In the psychiatric area, the use of inclusive language is fundamental to ensure that all patients feel welcomed and respected. This is especially important when considering that many psychiatric conditions are associated with stigma and prejudice, such as anxiety disorders, depression, and schizophrenia.

By using inclusive language, psychiatric professionals can contribute to reducing these stigmas and prejudices. This is because inclusive language recognizes and values human diversity, while promoting empathy and understanding between people.

Some examples of inclusive language practices in psychiatry include using neutral pronouns (such as "she/he" or "they/them") to refer to non-binary gender patients, using terms that avoid gender or racial stereotypes (such as "person with bipolar disorder" instead of "bipolar" or "black person" instead of "black"), and using clear and accessible language for patients with different levels of education.

JBP recommends consulting the recommendation of the APA - American Psychology Association Equity, diversity and inclusion available at:



Manuscript Category


JBP strongly encourages authors to ensure that their manuscripts meet the quality standards established by the guidelines for health research production - Enhancing the Quality and Transparency of Health Research Network (EQUATOR) ( EQUATOR is a directory that provides guidelines aimed at improving the reliability of published health research literature, promoting transparent and accurate reporting.

  • Original Articles: reports of original studies that provide an advance in clinical and experimental research and must contain new data from a representative number of participants using appropriate and reliable methods. Original articles should contain a maximum of 4,000 words and 40 references.
    • JBP supports the policies for clinical trial registration of the World Health Organization (WHO) and the ICMJE, recognizing the importance of these initiatives for the registration and international dissemination of information on clinical studies in open access. Therefore, only clinical research articles that have received an identification number in one of the Trial Registries validated by the criteria established by the WHO and the ICMJE, such as the Brazilian Registry of Clinical Trials - REBEC -, Clinical Trial ( among others, will be accepted for publication. The registration identification number should be inserted in the "Methods" section.
    • Randomized studies should follow CONSORT guidelines ( CONSORT provides an evidence-based approach to improving the quality of clinical trial reports. All manuscripts describing a clinical trial should include the CONSORT Flow Diagram showing the number of participants in each intervention group, as well as a detailed description of how many patients were excluded at each step of data analysis. All clinical tests must be registered and made available on an open-access website. The clinical trial protocol (including the complete statistical analysis plan) should be submitted with the manuscript (
    • Observational studies: cohort, case-control or cross-sectional designs should be reported according to the STROBE statement -, and should be submitted with their protocols.
    • Genetic association studies should be reported according to the STREGA guidelines -
  • Review Articles: articles that employ systematic methods and explicit criteria to identify, select, and critically evaluate relevant research, and to collect and analyze data from the studies included in the review. This category includes systematic reviews, integrative and narrative with or without meta-analyses. The reviews should contain up to 6,000 words and 120 references.
  • Special Articles: commissioned or pre-approved by the editors addressing the history of Psychiatry or other topics relevant to Psychiatry and Mental Health. Special articles should contain between 3000 to 5000 words and up to 50 references.
  • Brief Reports: small reports of original studies, evaluations or pilot studies, containing a maximum of 2,000 words and 15 references.
  • Case Reports: should provide a description of particularly interesting cases about patients, groups or events and should contain up to 1500 words and 15 references. In this category, the Case Report Guidelines - CARE - - are recommended.
  • Letters to the Editor: communications that discuss recently published articles in this journal, describing original research, case reports, or relevant scientific discoveries. Letters to the Editor should contain a maximum of 500 words and five (05) references.
  • Editorials: evidence-based critical comments made by researchers with extensive experience in a specific area of knowledge, at the request of the editors of this journal. Editorials should contain a maximum of 900 words and five (05) references.

Checklist: Maximum number of words and references according to article category:


Word Counts


Original Article



Review Article



Special Articles

3.000 a 5.000


Brief Reports



Case Reports



Letters to the Editor








Manuscript Preparation


The manuscript should be submitted in Word format (.doc or .docx). The text should be typed on A4 paper, using Times New Roman font, size 12, with margins of 3 cm and 2 cm, left to right, using a line spacing of 1.5 and justified alignment to the left.


JBP requests that the manuscript be submitted in separate files as follows:

Title Page:

  • Title: the title should be concise and informative and should not contain abbreviations. Titles in Portuguese should be translated into English.
  • Short title: the short title should contain up to five words and up to 50 characters (with spaces).Different from the title, the short title must also appear at the top of each page of the manuscript (in the same language that it was written).
  • Authors: full name of the authors with their respective academic degrees.
  • Affiliation: the affiliation of each author should contain the following information: university, department, city, ZIP code, country, email, and ORCID (all authors should have the ORCID identifier - Open Researcher and Contributor ID - A corresponding author must be indicated.
  • Authors' Responsibilities: each author must attest to having participated sufficiently in the work to assume responsibility for a significant portion of the manuscript's content. All contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section, as well as the financial support of funding agencies. The following criteria are requested according to the ICMJE:
    • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work;
    • Drafting the work or revising it critically for important intellectual content;
    • Final approval of the version to be published; and
    • Consent to be responsible for all aspects of the work, ensuring that issues related to the accuracy or integrity of any part of the work are properly investigated and resolved.
  • Abstract: the abstract should not exceed 250 words and be in four (04) sections: (1) introduction, (2) methods, (3) results, and (4) conclusions. Abstracts in Portuguese should be translated into English.
  • Keywords: three to five keywords should be included. JBP recommends that keywords be consulted in MeSH (Medical Subject Headings), the controlled vocabulary of the National Library of Medicine (NLM):
  • Funding Statement: authors must declare how their article's research and publication were funded, naming the body(s) that financially supported it (written in full), followed by associated grant number(s) in brackets (if applicable), for example: "this work was supported by the National Council for Scientific and Technological Development - CNPq [Grant Number/Year]. If the research did not receive specific funding but was carried out as part of the authors' employment, include the employer's name.
  • Acknowledgments: contributors who made substantial contributions to the manuscript (e.g., data collection, analysis and writing, or editing assistance) but do not meet authorship criteria should be named with their specific contributions in the Acknowledgments in the manuscript.

Manuscripts should follow the recommendations of the Equator Network guidelines - ( The body of the text should not contain any information such as the authors' names or affiliations. It should be structured as follows:

Original Articles, Reviews, Special Articles, and Brief Reports: Introduction, Methods, Results, Discussion, Conclusions, Individual Contributions, Conflicts of Interest, Acknowledgments and References.

Case Reports: Introduction, Case Report or Series of Cases (with subdivisions: Patient Information, Clinical Findings, Diagnosis, Intervention and Assessment, and Outcomes), Discussion, Conclusion, Individual Contributions, Conflicts of Interest, Acknowledgments and References.

Letters to the Editor and Editorials: The contents can be structured into sections at the author's discretion.

Introduction: It should include a brief review of all literature directly related to the subject in question. Additionally, it should describe the objectives of the study.

Methods: It should report the study design and describe in detail the methods employed in a way that allows other authors to replicate it.

Results: They should be described logically, sequentially, and succinctly, occasionally using the aid of tables and figures.

Discussion: The discussion should be limited to highlighting the study's conclusions, considering the similarities and differences between its results and those of other authors, the implications of its results, the limitations of the study, and future perspectives.

Conclusions: The authors should specify, preferably in a short and concise paragraph, only the conclusions that can be supported by the study's data, as well as their clinical importance (without excessive generalizations).

References: They should follow the Vancouver style (Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Medical Publication), arranged according to their citation in the text. The references should be identified in the text with Arabic numerals, superscripts, and enclosed in square brackets, following the order of citation in the text. Examples of references are available on the following website:

Units and Measures: They should be presented simply and concisely using the International System of Units (SI).

Figures and Tables: Figures and Tables should not be sent in separate files. The tables should not contain data already cited in the text. They should be open on the sides and with a completely white background. Each table should have a descriptive title, and if numerical measurements are provided, the units should be included in the column header. If the manuscript is accepted, the authors may be asked to provide the source files for the figures. All figures should be cited in the manuscript in consecutive order. Only images in TIFF or JPEG formats will be accepted, with a minimum resolution according to the type of image, both for black and white images and for color images: 1200 dpi for simple black and white graphics, 300 dpi for black and white photographs, and 600 dpi for color photographs.

Supplementary Materials: Supplementary materials are additional parts of a manuscript, such as audio files, videos, or data sets that may be of interest to readers. Authors can submit the supplementary material file along with their manuscript in the submission process. A section titled Supplementary Material should be included before the reference list with a concise description for each supplementary material file. The supplementary materials are not modified by the JBP editorial team. The authors are responsible for providing the final files of the supplementary material that will be published along with the article.



Submission Process


Manuscripts must be submitted and filled out online through the ScholarOne system - accompanied by:

  • Cover Letter signed by the corresponding author, where authors must explain why they believe the submitted manuscript is suitable for publication in JBP, highlighting its relevance and innovative aspects. The authors must declare that the submitted manuscript represents original material, has not been previously published, and is not being evaluated for publication elsewhere;
  • Conflict of Interest Statement from each author;
  • Title Page;
  • Manuscript;
  • Permission letter
    Authors are required to fill a permission letter and submit it along with the manuscript:

    "The undersigned authors hereby approves submission of this work and all subsequent for publication and transfer, assign, or otherwise convey all copyright ownership to the Brazilian Journal of Psychiatry.  Also, the undersigned authors warrant that this work represents original material and does not infringe upon the copyright of any third party; that no part of the work has been published or will be submitted for publication elsewhere unless and until it is rejected by Brazilian Journal of Psychiatry. Finally, the authors agree to indemnify the Publisher against any loss or damages arising out of a breach of this agreement. In the event that our submission is not published, copyright ownership shall revert to the Author(s)."
    All authors need to sign the permission letter and include their complete name, addresses for postage, phone, and e-mail. They ought to scan and submit it for the Editors through the ScholarOne System.
  • After the manuscript is accepted: Authors' Statement signed by all authors of the manuscript.


Peer Review Process

  JBP adopts the Single Anonymous process.  After receiving the manuscript through ScholarOne, the editors will judge whether it will be reviewed by anonymous reviewers. The decision will be based on the publication focus, originality, and relevance of the manuscript to the field. Next, the manuscript will be sent to at least two anonymous and independent reviewers (who are not necessarily those suggested by the authors). The JBP editors strive to maintain a fast publication process. Usually, the period between submission and acceptance of the manuscript is about three months. The authors will receive an email from the editors with their final decision and a copy of the reviewers' comments. In case the manuscript review is indicated, the authors must submit a final text with the necessary changes (responding to each item raised by the reviewers), following the editors' instructions. The authors must reproduce the item raised by the reviewer immediately before each of their responses. Sending only the responses separate from the items raised by the reviewers may identify the manuscript evaluation process. This entire process can be tracked by the authors through ScholarOne  




JBP accepts manuscripts that have been previously deposited in a non-commercial preprint server, provided they have not been submitted for peer review in another journal simultaneously. A preprint consists of a complete version of the scientific article that has not yet been peer-reviewed. Preprints operate independently of the journal, and publishing a preprint does not affect the peer-review process.

JBP only accepts preprints if the responsible author for the submission informs in which preprint server the manuscript is deposited and must provide the corresponding DOI. The manuscript must also comply with a license that allows sharing the material in any medium or format (Creative Commons - CC-BY)

JBP requests the completion of the Open Science Compliance Form, which must be submitted as a supplementary file to the manuscript and will be accessible to reviewers.

When a manuscript that has been published in a preprint repository is subsequently published as a peer-reviewed article, the official publication should be used as a reference. Preprints that are fundamental to the development of the manuscript or that cover important advances in the field, but have not yet been properly published, may be cited. Preprints should be explicitly identified as such, for example:

  • Li X, Lidsky P, Xiao Y, Wu CT, GarciaKnight M, Yang J, Nakayama T, Nayak JV, Jackson PK, Andino R, Shu X. Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models. bioRxiv [Preprint]. 2020 Nov 2:2020.10.28.359042. doi: 10.1101/2020.10.28.359042.
  • Data Reference: JBP encourages citing an underlying or relevant dataset in the manuscript by mentioning it in the text and including it in the References section. Data references should contain the following elements: author(s) name(s), dataset title, data repository, version (if available), year, and global persistent identifier. Example:
  • Research Data: Coin L. Genomics of development and disease [dataset]. 2014 Jun 1 [cited 2017 Jun 9]. The University of Queensland. Available from:
  • Repository Data: Dryad Digital Repository [Internet]. Durham (NC): Dryad. 2008 Jan - [cited 2014 Oct 3]. Available from:
  • Data deposited in Repositories: Kraemer MUG, Sinka ME, Duda KA, Mylne A, Shearer FM, Brady OJ, Messina JP, Barker CM, Moore CG, Carvalho RG, Coelho GE, Van Bortel W, Hendrickx G, Schaffner F, Wint GRW, Elyazar IRF, Teng H, Hay SI. The global compendium of Aedes aegypti and Ae. albopictus occurrence [dataset]. 2015 Jun 30 [cited 2015 Oct 23]. In: Dryad Digital Repository [Internet]. Durham (NC): Dryad. 2008 Jan - . 3 files: 3.406 MB; 1.549 MB; 1.815 MB. Available from: Referenced in doi: 10.7554/eLife.08347
  • Data described in articles: Kraemer MU, Sinka ME, Duda KA, Mylne A, Shearer FM, Brady OJ, Messina JP, Barker CM, Moore CG, Carvalho RG, Coelho GE, Van Bortel W, Hendrickx G, Schaffner F, Wint GR, Elyazar IR, Teng HJ, Hay SI.  The global compendium of Aedes aegypti and Ae. albopictus occurrence. Sci Data. 2015 Jul 7 [cited 2015 Oct 23];2:150035. Available from: doi: 10.1038/sdata.2015.35.

Preprint Review Process

JBP adopts the Single Anonymous process for preprints, in which reviewers are known to the preprint authors, but not the other way around. This helps to ensure that preprints submitted to the journal are critically and impartially evaluated before their possible publication in JBP.

JBP, whenever necessary, will request detailed information from preprint authors about the methodology used in the research, results obtained, and conclusions reached, so that reviewers can assess the quality of the work appropriately.

JBP may also request from authors information about peer review that the preprint has already received in another repository, if applicable, to help reviewers assess the quality of the work more fully.





The corresponding author will receive a proof, in text file (doc and docx), with the comments and changes made by the technical reading team. The deadline for proof revision is four days. If there are still doubts in this proof, the editorial team will contact you to review it until a final version of the text is reached.

Prior to the publication of accepted articles, the corresponding authors will receive the article in its finalized and edited version for approval the PROOF PDF file. To open these files, Acrobat Reader must be installed (free download at Corrections requested at this stage of the process should be limited to typographical errors, without altering the content of the study. Changes in content or authors will not be allowed. Authors must return the approved proofs via e-mail within 48 hours of receipt. Once the PDF production process is complete, the article will be sent for publication.




Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro Av. Venceslau Brás, 71 Fundos, 22295-140 Rio de Janeiro - RJ Brasil, Tel./Fax: (55 21) 3873-5510 - Rio de Janeiro - RJ - Brazil